van den Hurk, Corina J. G.
Sonis, Stephen T.
Epstein, Joel B.
Article History
First Online: 28 July 2022
Declarations
:
: Dr. van den Hurk received institutional implementation and research grants from AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Ipsen, and Merck.Dr. Sonis is an employee of Biomodels, LLC, and Primary Endpoint Solutions, LLC. Both companies assist industry, government, and academics to study and enable drugs, biologicals, and devices to treat patients for a broad range of indications including toxicities of cancer therapy. Dr. Sonis does not have equity or receive payment from any clients. Dr. Sonis is an Associate Editor for Supportive Care in Cancer.Dr. Epstein serves on an advisory role for Galera Therapeutics, Tosk Pharma, and Rakuten Medical. Dr. Epstein is an Associate Editor-in-Chief for Supportive Care in Cancer.
Free to read: This content has been made available to all.